154 related articles for article (PubMed ID: 9932559)
1. Stage IA1 cervical adenocarcinoma: definition and treatment.
Schorge JO; Lee KR; Flynn CE; Goodman A; Sheets EE
Obstet Gynecol; 1999 Feb; 93(2):219-22. PubMed ID: 9932559
[TBL] [Abstract][Full Text] [Related]
2. Early invasive adenocarcinoma of the uterine cervix: criteria for nonradical surgical treatment.
Kasamatsu T; Okada S; Tsuda H; Shiromizu K; Yamada T; Tsunematsu R; Ohmi K
Gynecol Oncol; 2002 May; 85(2):327-32. PubMed ID: 11972396
[TBL] [Abstract][Full Text] [Related]
3. Survival of women with microinvasive adenocarcinoma of the cervix is not improved by radical surgery.
Bean LM; Ward KK; Plaxe SC; McHale MT
Am J Obstet Gynecol; 2017 Sep; 217(3):332.e1-332.e6. PubMed ID: 28522318
[TBL] [Abstract][Full Text] [Related]
4. Do FIGO stage IA and small (≤2 cm) IB1 cervical adenocarcinomas have a good prognosis and warrant less radical surgery?
Al-Kalbani M; McVeigh G; Nagar H; McCluggage WG
Int J Gynecol Cancer; 2012 Feb; 22(2):291-5. PubMed ID: 22080884
[TBL] [Abstract][Full Text] [Related]
5. Surgical treatment and outcome of early invasive adenocarcinoma of the uterine cervix (FIGO stage IA1).
Yahata H; Sonoda K; Yasunaga M; Ohgami T; Kawano Y; Kaneki E; Okugawa K; Kaku T; Kato K
Asia Pac J Clin Oncol; 2018 Apr; 14(2):e50-e53. PubMed ID: 28429457
[TBL] [Abstract][Full Text] [Related]
6. Surgical treatment of microinvasive cervical cancer: analysis of pathologic features with implications on radicality.
Yoneda JY; Braganca JF; Sarian LO; Borba PP; Conceição JC; Zeferino LC
Int J Gynecol Cancer; 2015 May; 25(4):694-8. PubMed ID: 25742569
[TBL] [Abstract][Full Text] [Related]
7. Conservative therapy in microinvasive adenocarcinoma of the uterine cervix is justified: an analysis of 59 cases and a review of the literature.
Baalbergen A; Smedts F; Helmerhorst TJ
Int J Gynecol Cancer; 2011 Dec; 21(9):1640-5. PubMed ID: 21897274
[TBL] [Abstract][Full Text] [Related]
8. Is there a difference in survival for IA1 and IA2 adenocarcinoma of the uterine cervix?
Smith HO; Qualls CR; Romero AA; Webb JC; Dorin MH; Padilla LA; Key CR
Gynecol Oncol; 2002 May; 85(2):229-41. PubMed ID: 11972381
[TBL] [Abstract][Full Text] [Related]
9. Analysis of outcomes of microinvasive adenocarcinoma of the uterine cervix by treatment type.
Reynolds EA; Tierney K; Keeney GL; Felix JC; Weaver AL; Roman LD; Cliby WA
Obstet Gynecol; 2010 Nov; 116(5):1150-7. PubMed ID: 20966701
[TBL] [Abstract][Full Text] [Related]
10. Conservative treatment of stage IA1 adenocarcinoma of the uterine cervix with a long-term follow-up.
Yahata T; Nishino K; Kashima K; Sekine M; Fujita K; Sasagawa M; Honma S; Kodama S; Tanaka K
Int J Gynecol Cancer; 2010 Aug; 20(6):1063-6. PubMed ID: 20683418
[TBL] [Abstract][Full Text] [Related]
11. Conservative treatment of stage IA1 adenocarcinoma of the cervix during pregnancy.
Yahata T; Numata M; Kashima K; Sekine M; Fujita K; Yamamoto T; Tanaka K
Gynecol Oncol; 2008 Apr; 109(1):49-52. PubMed ID: 18289649
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the prognoses of FIGO stage I to stage II adenosquamous carcinoma and adenocarcinoma of the uterine cervix treated with radical hysterectomy.
Mabuchi S; Okazawa M; Kinose Y; Matsuo K; Fujiwara M; Suzuki O; Morii E; Kamiura S; Ogawa K; Kimura T
Int J Gynecol Cancer; 2012 Oct; 22(8):1389-97. PubMed ID: 22976497
[TBL] [Abstract][Full Text] [Related]
13. Early cervical adenocarcinoma: selection criteria for radical surgery.
Schorge JO; Lee KR; Lee SJ; Flynn CE; Goodman A; Sheets EE
Obstet Gynecol; 1999 Sep; 94(3):386-90. PubMed ID: 10472864
[TBL] [Abstract][Full Text] [Related]
14. Is the invasion depth in millimeters valid to determine the prognosis of early invasive cervical adenocarcinoma? A case of recurrent FIGO stage IA1 cervical adenocarcinoma.
Utsugi K; Shimizu Y; Akiyama F; Hasumi K
Gynecol Oncol; 2001 Jul; 82(1):205-7. PubMed ID: 11426988
[TBL] [Abstract][Full Text] [Related]
15. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis.
dos Reis R; Frumovitz M; Milam MR; Capp E; Sun CC; Coleman RL; Ramirez PT
Gynecol Oncol; 2007 Dec; 107(3):458-63. PubMed ID: 17854872
[TBL] [Abstract][Full Text] [Related]
16. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy.
Takeda N; Sakuragi N; Takeda M; Okamoto K; Kuwabara M; Negishi H; Oikawa M; Yamamoto R; Yamada H; Fujimoto S
Acta Obstet Gynecol Scand; 2002 Dec; 81(12):1144-51. PubMed ID: 12519111
[TBL] [Abstract][Full Text] [Related]
17. Conservative treatment of microinvasive adenocarcinoma of uterine cervix: long-term follow-up.
Sopracordevole F; Canzonieri V; Giorda G; De Piero G; Lucia E; Campagnutta E
J Low Genit Tract Dis; 2012 Oct; 16(4):381-6. PubMed ID: 22302130
[TBL] [Abstract][Full Text] [Related]
18. Laparoendoscopic single-site radical hysterectomy with pelvic lymphadenectomy: initial multi-institutional experience for treatment of invasive cervical cancer.
Boruta DM; Fagotti A; Bradford LS; Escobar PF; Scambia G; Kushnir CL; Michener CM; Fader AN
J Minim Invasive Gynecol; 2014; 21(3):394-8. PubMed ID: 24161887
[TBL] [Abstract][Full Text] [Related]
19. Fertility sparing treatment for in situ and early invasive adenocarcinoma of the cervix.
McHale MT; Le TD; Burger RA; Gu M; Rutgers JL; Monk BJ
Obstet Gynecol; 2001 Nov; 98(5 Pt 1):726-31. PubMed ID: 11704160
[TBL] [Abstract][Full Text] [Related]
20. Microinvasive cervical adenocarcinoma (FIGO stage 1A tumors): results of surgical staging and outcome analysis.
Ceballos KM; Shaw D; Daya D
Am J Surg Pathol; 2006 Mar; 30(3):370-4. PubMed ID: 16538058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
